BL9B Stock Overview
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Balchem Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$129.90 |
| 52 Week High | US$145.80 |
| 52 Week Low | US$108.70 |
| Beta | 0.70 |
| 1 Month Change | -7.87% |
| 3 Month Change | 1.33% |
| 1 Year Change | 13.55% |
| 3 Year Change | 26.48% |
| 5 Year Change | 47.41% |
| Change since IPO | 505.59% |
Recent News & Updates
Recent updates
Shareholder Returns
| BL9B | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | -3.8% | -1.6% | 0.5% |
| 1Y | 13.5% | 0.9% | 1.3% |
Return vs Industry: BL9B exceeded the German Chemicals industry which returned -0.3% over the past year.
Return vs Market: BL9B exceeded the German Market which returned 2.3% over the past year.
Price Volatility
| BL9B volatility | |
|---|---|
| BL9B Average Weekly Movement | 2.8% |
| Chemicals Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: BL9B has not had significant price volatility in the past 3 months.
Volatility Over Time: BL9B's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 1,302 | Ted Harris | www.balchem.com |
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Balchem Corporation Fundamentals Summary
| BL9B fundamental statistics | |
|---|---|
| Market cap | €4.23b |
| Earnings (TTM) | €101.18m |
| Revenue (TTM) | €859.90m |
41.2x
P/E Ratio4.8x
P/S RatioIs BL9B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BL9B income statement (TTM) | |
|---|---|
| Revenue | US$922.44m |
| Cost of Revenue | US$620.38m |
| Gross Profit | US$302.06m |
| Other Expenses | US$193.51m |
| Earnings | US$108.54m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 03, 2024
| Earnings per share (EPS) | 3.36 |
| Gross Margin | 32.75% |
| Net Profit Margin | 11.77% |
| Debt/Equity Ratio | 29.4% |
How did BL9B perform over the long term?
See historical performance and comparison